XML 33 R23.htm IDEA: XBRL DOCUMENT
v3.22.2

Revenue (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Revenue From Contract With Customer [Abstract] |
Schedule of Disaggregated Revenue | The following table presents our disaggregated revenue for the periods presented (in thousands):
|  | Three Months Ended June 30, |  |  | Six Months Ended June 30, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Immune Medicine revenue |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Service revenue |  | $ | 7,296 |  |  | $ | 5,405 |  |  | $ | 14,409 |  |  | $ | 9,453 |
Collaboration revenue |  |  | 15,082 |  |  |  | 17,634 |  |  |  | 28,785 |  |  |  | 33,691 |
Total Immune Medicine revenue |  |  | 22,378 |  |  |  | 23,039 |  |  |  | 43,194 |  |  |  | 43,144 |
MRD revenue |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Service revenue |  |  | 20,282 |  |  |  | 13,966 |  |  |  | 35,086 |  |  |  | 25,303 |
Regulatory milestone revenue |  |  | 1,000 |  |  |  | 1,500 |  |  |  | 4,000 |  |  |  | 8,500 |
Total MRD revenue |  |  | 21,282 |  |  |  | 15,466 |  |  |  | 39,086 |  |  |  | 33,803 |
Total revenue |  | $ | 43,660 |  |  | $ | 38,505 |  |  | $ | 82,280 |  |  | $ | 76,947 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration